Background: The present study investigated the effect of fenugreek seeds powder and its alcoholic extract on metabolic activity of drug-metabolizing enzymes CYP2D6 and CYP3A4. Materials and Methods: Dextromethorphan (DEX) was used as a probe for measuring metabolic activity, based on its CYP2D6- and CYP3A4-mediated metabolism to dextrorphan (DOR) and 3-methoxymorphinan (3-MM), respectively. For the in vitro investigations, DEX (25µM) was incubated with human liver microsomes and NADPH and tested with and without the fenugreek extract. For the in vivo study, phase I, 6 subjects received a single dose of DEX (30 mg); in phase II, after washout period, the fenugreek seeds powder was administered for 1 week and DEX was administered with its last dose. Results: In vitro, fenugreek extract inhibits CYP2D6-mediated O-demethylation of DEX. Higher concentrations (50 and 100µg/ml) of extract inhibit CYP2D6 and CYP3A4 activity. In vivo results indicated that fenugreek does not significantly inhibit CYP2D6 and CYP3A4 metabolic activity. There was no significant change in the levels of DEX metabolites (DOR 12% and 3-MM 9%) excreted in urine and their urine metabolic ratios (P values: 0.257 and 0.333 DEX/DOR and DEX/3-MM, respectively). Conclusion: In vitro and in vivo observations suggested that fenugreek may not have substantial effect on the metabolic activity of CYP2D6 and CYP3A4.

1.
Müller AC, Kanfer I: Potential pharmacokinetic interactions between antiretrovirals and medicinal plants used as complementary and African traditional medicines. Biopharm Drug Dispos 2011;32:458-470.
2.
Moschella C, Jaber BL: Interaction between cyclosporine-A and Hypericumperforatum (St. John's wort) after organ transplantation. Am J Kidney Dis 2001;38:1105-1107.
3.
Zhou S, Lim LY, Chowbay B: Herbal modulation of P-glycoprotein. Drug Metab Rev 2004;36:57-104.
4.
Barone GW, Gurley BJ, Ketel BL, Lightfoot ML, Abul-Ezz SR: Drug interaction between St. John's wort and cyclosporine-A. Ann Pharmacother 2004;34:1013-1016.
5.
Yamasaki I, Yamada M, Uotsu N, Teramoto S, Takayanagi R, Yamada Y: Inhibitory effects of kale ingestion on metabolism by cytochrome P450 enzymes in rats. Biomed Res 2012;33:235-242.
6.
Taesotikul T, Dumrongsakulchai W, Wattanachai N, et al.: Inhibitory effects of Phyllanthus amarus and its major lignans on human microsomal cytochrome P450 activities: evidence for CYP3A4 mechanism-based inhibition. Drug Metab Pharmacokinet 2011;26:154-161.
7.
Wang X, Cheung CM, Lee WY, Or PM, Yeung JH: Major tanshinones of Danshen (Salvia miltiorrhiza) exhibit different modes of inhibition on human CYP1A2, CYP2C9, CYP2E1 and CYP3A4 activities in vitro. Phytomedicine 2010;17:868-875.
8.
Hassanzadeh E, Chaichi MR, Mazaheri D, Rezazadeh S, Badi HAN: Physical and chemical variabilities among domestic Iranian Trigonella foenum-graecum (Trigonella foenum-graceum) seeds. Asian J Plant Sci 2011;10:323-330.
9.
Petropoulos GA: Fenugreek - The Genus Trigonella, ed 11. London, Taylor & Francis, 2002.
10.
Al-Jasass FM, Al-Jasser MS: Chemical composition and fatty acid content of some spices and herbs under Saudi Arabia conditions. ScientificWorldJournal 2012;2012:859892.
11.
Kaviarasan S, Ramamurthy N, Gunasekaran P, Varalakshmi E, Anuradha CV: Induction of alcohol-metabolizing enzymes and heat shock protein expression by ethanol and modulation by fenugreek seed polyphenols in Chang liver cells. Toxicol Mech Methods 2009;19:116-122.
12.
Kaviarasan S, Anuradha CV: Fenugreek (Trigonella foenum graecum) seed polyphenols protect liver from alcohol toxicity: a role on hepatic detoxification system and apoptosis. Pharmazie 2007;62:299-304.
13.
Sambaiah K, Srinivasan K: Influence of spices and spice principles on hepatic mixed function oxygenase system in rats. Indian J Biochem Biophys 1989;26:254-258.
14.
Korashy HM, Al-Jenoobi FI, Raish M, Ahad A, Al-Mohizea AM, Alam MA, Alkharfy KM, Al-Suwayeh SA: Impact of herbal medicines like Nigella sativa, Trigonella foenum-graecum, and Ferula asafoetida, on cytochrome P450 2C11 gene expression in rat liver. Drug Res (Stuttg) 2014;6:Epub ahead of print.
15.
Al-Jenoobi FI, Korashy HM, Ahad A, Raish M, Al-Mohizea AM, Alam MA, Al-Suwayeh SA, Alkharfy KM: Potential inhibitory effect of herbal medicines on rat hepatic cytochrome P450 2D gene expression and metabolic activity. Pharmazie 2014;69:799-803.
16.
Lewis DF, Modi S, Dickins M: Structure-activity relationship for human cytochrome P450 substrates and inhibitors. Drug Metab Rev 2002;34:69-82.
17.
Barnhart JW: The urinary excretion of dextromethorphan and three metabolites in dogs and humans. Toxicol Appl Pharmacol 1980;55:43-48.
18.
Gorski JC, Jones DR, Wrighton SA, Hall SD: Characterization of dextromethorphan N-demethylation by human liver microsomes. Biochem Pharmacol 1994;48:173-182.
19.
Kerry NL, Somogyi AA, Bochner F, Mikus G: The role of CYP2D6 in primary and secondary oxidative metabolism of dextromethorphan: in vitro studies using human liver microsomes. Br J Clin Pharmacol 1994;38:243-248.
20.
Yu A, Haining RL: Comparative contribution to dextromethorphan metabolism by cytochrome P450 isoforms in vitro: can dextromethorphan be used as a dual probe for both CYP2D6 and CYP3A activities? Drug Metab Dispos 2001;29:1514-1120.
21.
Ducharme J, Abddullah S, Wainer IW: Dextromethorphan as an in vivo probe for the simultaneous determination of CYP2D6 and CYP3A activity. J Chromatogr B Biomed Appl 1996;678:113-128.
22.
Funck-Brentano C, Boelle PY, Verstuyft C, Bornert C, Becquemont L, Poirier JM: Measurement of CYP2D6 and CYP3A4 activity in vivo with dextromethorphan: sources of variability and predictors of adverse effects in 419 healthy subjects. Eur J Clin Pharmacol 2005;61:821-829.
23.
Bendriss EK, Markoglou N, Wainer IW: High performance liquid chromatography assay for simultaneous determination of dextromethorphan and its main metabolites in urine and in microsomal preparations. J Chromatogr B 2001;754:209-215.
24.
Min DI, Ku YM, Vichiendilokkul A, Fleckenstein LL: A urine metabolic ratio of dextromethorphan and 3-methoxymorphinan as a probe for CYP3A activity and prediction of cyclosporine clearance in healthy volunteers. Pharmacotherapy 1999;19:753-759.
You do not currently have access to this content.